Article
DSCN: double-target selection guided by CRISPR screening and network
2021-09-06
Abstract excerpt
Cancer is a complex disease with usually multiple disease mechanisms. Target combination is a better strategy than a single target in developing cancer therapies. However, target combinations are generally more difficult to be predicted. C urrent CRISPR-cas9 technology enables genome-wide screening for potential targets, but only a handful of genes have been screend as target combinations. Thus, an effective comp...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- aad6db47-4e31-5b9d-a0c0-24a3e205f63c
- DOI
- 10.1101/2021.09.06.459081
